Long-Term Efficacy and Quality of Life with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Pediatric, Adolescent, and Adult Subjects with Target Joints and Severe Hemophilia a

Saved in:
Bibliographic Details
Published inBlood Vol. 128; p. 3791
Main Authors Ingrid Pabinger, Nisha Jain, Bent Winding, Elisa Tsao, Raina Liesner, K. John Pasi, Stefan Lethagen, Michael Wang, Hideji Hanabusa, Bryce A. Kerlin, Beatrice Nolan, Roshni Kulkarni, Simon A Brown
Format Journal Article
LanguageJapanese
Published American Society of Hematology 02.12.2016
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.v128.22.3791.3791